A novel sustained-release immunotoxin for treatment of glioblastoma multiforme
Research Grant
Administered By
Biomedical Engineering
Awarded By
National Institutes of Health
Start Date
February 1, 2019
End Date
January 31, 2021
Administered By
Biomedical Engineering
Awarded By
National Institutes of Health
Start Date
February 1, 2019
End Date
January 31, 2021